BRIEF — Orexo Completes First Preclinical Study Of Oral Semaglutide Tablet

Oct 14 (Reuters) — Orexo AB: Completes First Preclinical Study Of Oral Semaglutide Tablet Using Amorphox Technology Prior To Any Optimization Lead Amorphox Oral Semaglutide Tablet Demonstrated Bioavailability Comparable To That Of Reference Tablet Results Provide An Encouraging Starting Point For Further Formulation Optimization Source text:... Further company coverage: ORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;)